Martha Eibl

Title: Martha Eibl: Innovator in Immunology

Introduction

Martha Eibl is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of immunology, particularly in the isolation and application of immunoglobulins. With a total of 4 patents to her name, her work has advanced the understanding and treatment of inflammation.

Latest Patents

Martha Eibl's latest patents include a process for isolating IgG and IgA. This method involves adsorbing IgG and optionally IgA to a solid inorganic carrier material. The process is characterized by the isolation of IgA from the eluate, while IgG remains on the carrier material. Additionally, IgG can be isolated from the adsorbate. Another notable patent describes a composition and method for preventing and treating inflammation using IgA preparations. These preparations can effect immunomodulation and are preferably multimeric IgA, essentially free of IgG. The patents also suggest the use of immunoglobulin A in vaccines to prevent inflammation.

Career Highlights

Martha Eibl has worked with notable companies such as Immuno Aktiengesellschaft and Immuno Aktiengesellschaft für Chemisch-medizinische Produkte. Her career has been marked by a commitment to advancing immunological research and developing innovative solutions for health challenges.

Collaborations

Martha has collaborated with esteemed colleagues, including Hermann Wolf and Heinz Leibl. These partnerships have contributed to her success and the impact of her inventions in the field.

Conclusion

Martha Eibl's contributions to immunology through her patents and collaborations highlight her role as a leading inventor in the field. Her innovative approaches to isolating immunoglobulins and treating inflammation continue to influence medical research and applications.